A patient-derived explant (PDE) model of hormone-dependent cancer

Identification of novel response and predictive biomarkers to Hsp90 inhibitors through mass spectrometry-based proteomic profiling of patient-derived prostate tumor explants

(2018) Elizabeth V Nguyen et al.   MOLECULAR & CELLULAR PROTEOMICS

Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion

(2018) Heather K. Armstrong et al.   Scientific Reports

Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models

(2018) Gail P. Risbridger et al.   Cold Spring Harbor Perspectives in Medicine

Ki67 assessment in breast cancer: an update

(2017) Frederique Penault-Llorca et al.   PATHOLOGY

Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial

(2016) David F. Penson et al.   JOURNAL OF CLINICAL ONCOLOGY

Progesterone Receptor Signaling Mechanisms

(2016) Sandra L. Grimm et al.   JOURNAL OF MOLECULAR BIOLOGY

Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

(2016) Neal D Shore et al.   LANCET ONCOLOGY

Organoid culture systems for prostate epithelial and cancer tissue

(2016) Jarno Drost et al.   Nature Protocols

Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer

(2016) H. Singhal et al.   Science Advances

Novel Actions of Next-Generation Taxanes Benefit Advanced Stages of Prostate Cancer

(2015) R. de Leeuw et al.   CLINICAL CANCER RESEARCH

Oncologic Outcomes at 10 Years Following Robotic Radical Prostatectomy

(2015) Mireya Diaz et al.   EUROPEAN UROLOGY

Progesterone receptor modulates ERα action in breast cancer

(2015) Hisham Mohammed et al.   NATURE

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

(2014) Dong Gao et al.   CELL

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort

(2013) G Fisher et al.   BRITISH JOURNAL OF CANCER

Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling

(2013) K. I. Pishas et al.   CANCER RESEARCH

The Mutational Landscape of Prostate Cancer

(2013) Christopher E. Barbieri et al.   EUROPEAN UROLOGY

EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer

(2013) Axel Heidenreich et al.   EUROPEAN UROLOGY

The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?

(2013) Monica Arnedos et al.   JOURNAL OF PATHOLOGY

A preclinical xenograft model of prostate cancer using human tumors

(2013) Mitchell G Lawrence et al.   Nature Protocols

Ex vivo culture of human prostate tissue and drug development

(2013) Margaret M. Centenera et al.   Nature Reviews Urology

Targeting cell cycle and hormone receptor pathways in cancer

(2013) C E S Comstock et al.   ONCOGENE

Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors

(2012) Jeffry L. Dean et al.   CELL CYCLE

Evidence for Efficacy of New Hsp90 Inhibitors Revealed by Ex Vivo Culture of Human Prostate Tumors

(2012) M. M. Centenera et al.   CLINICAL CANCER RESEARCH

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer

(2012) Caryn S. Ross-Innes et al.   NATURE

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

(2012) Christina Curtis et al.   NATURE

Dual Roles of PARP-1 Promote Cancer Growth and Progression

(2012) M. J. Schiewer et al.   Cancer Discovery

New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway

(2011) G. Attard et al.   CLINICAL CANCER RESEARCH

Fast and accurate short read alignment with Burrows-Wheeler transform

(2009) H. Li et al.   BIOINFORMATICS

Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer

(2008) Tobias Zellweger et al.   INTERNATIONAL JOURNAL OF CANCER

Model-based Analysis of ChIP-Seq (MACS)

(2008) Yong Zhang et al.   GENOME BIOLOGY